Brassica rapa hairy root based expression system leads to the production of highly homogenous and reproducible profiles of recombinant human alpha-L-iduronidase.


Journal

Plant biotechnology journal
ISSN: 1467-7652
Titre abrégé: Plant Biotechnol J
Pays: England
ID NLM: 101201889

Informations de publication

Date de publication:
02 2019
Historique:
received: 18 01 2018
revised: 02 05 2018
accepted: 22 07 2018
pubmed: 31 7 2018
medline: 4 6 2019
entrez: 31 7 2018
Statut: ppublish

Résumé

The Brassica rapa hairy root based expression platform, a turnip hairy root based expression system, is able to produce human complex glycoproteins such as the alpha-L-iduronidase (IDUA) with an activity similar to the one produced by Chinese Hamster Ovary (CHO) cells. In this article, a particular attention has been paid to the N- and O-glycosylation that characterize the alpha-L-iduronidase produced using this hairy root based system. This analysis showed that the recombinant protein is characterized by highly homogeneous post translational profiles enabling a strong batch to batch reproducibility. Indeed, on each of the 6 N-glycosylation sites of the IDUA, a single N-glycan composed of a core Man

Identifiants

pubmed: 30058762
doi: 10.1111/pbi.12994
pmc: PMC6335068
doi:

Substances chimiques

Epitopes 0
Polysaccharides 0
Recombinant Proteins 0
Fucose 28RYY2IV3F
Xylose A1TA934AKO
IDUA protein, human EC 3.2.1.76
Iduronidase EC 3.2.1.76
Mannose PHA4727WTP

Banques de données

GENBANK
['NP_000194.2']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

505-516

Subventions

Organisme : BPI France
Pays : International
Organisme : Région Hauts de France
Pays : International

Informations de copyright

© 2018 The Authors. Plant Biotechnology Journal published by Society for Experimental Biology and The Association of Applied Biologists and John Wiley & Sons Ltd.

Références

Gene. 1992 Dec 15;122(2):383-4
pubmed: 1336757
Traffic. 2015 Jul;16(7):743-59
pubmed: 25786328
Appl Microbiol Biotechnol. 2007 Apr;74(6):1175-85
pubmed: 17294182
Biotechnol Bioeng. 2013 Apr;110(4):1164-73
pubmed: 23124363
Nat Commun. 2012;3:1062
pubmed: 22990858
Mol Ther. 2006 Jan;13(1):135-41
pubmed: 16153895
Plant Biotechnol J. 2011 Dec;9(9):991-1001
pubmed: 21740504
Biotechnol Bioeng. 1997 Jun 5;54(5):401-15
pubmed: 18634133
Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15908-13
pubmed: 18838694
Biosci Rep. 2013 Sep 25;33(5):
pubmed: 23980545
J Biol Chem. 2004 Aug 13;279(33):35037-46
pubmed: 15170390
Biotechnol J. 2012 Dec;7(12):1473-84
pubmed: 23027660
Exp Cell Res. 1968 Apr;50(1):151-8
pubmed: 5650857
Trends Biotechnol. 2006 Sep;24(9):403-9
pubmed: 16870285
Nat Biotechnol. 2001 Jul;19(7):640-4
pubmed: 11433275
J Proteomics. 2013 Mar 27;80:26-33
pubmed: 23026551
Sci Rep. 2015 Sep 18;5:14144
pubmed: 26382970
Mol Genet Metab. 2014 Feb;111(2):113-5
pubmed: 24332804
Mol Cell Proteomics. 2013 Nov;12(11):3160-83
pubmed: 23912651
PLoS One. 2015 Oct 05;10(10):e0139282
pubmed: 26437211
Protein Expr Purif. 1994 Jun;5(3):225-32
pubmed: 7950365
Biotechnol Lett. 2014 Jan;36(1):181-90
pubmed: 24078130
Biotechnol Bioeng. 2008 Feb 1;99(2):475-84
pubmed: 17680664
Semin Cell Dev Biol. 2018 Aug;80:133-141
pubmed: 28688929
Nat Biotechnol. 2006 Oct;24(10):1241-52
pubmed: 17033665
Glycobiology. 2009 Sep;19(9):936-49
pubmed: 19494347
J Biol Chem. 1997 Sep 5;272(36):22758-65
pubmed: 9278435
Crit Rev Biotechnol. 2007 Jan-Mar;27(1):29-43
pubmed: 17364688
Nanomedicine. 2012 Jul;8(5):731-9
pubmed: 21906578
J Neurochem. 2008 Feb;104(4):1055-64
pubmed: 17986221
Curr Opin Plant Biol. 2006 Jun;9(3):341-6
pubmed: 16616871
Methods Mol Biol. 2004;267:351-63
pubmed: 15269436
Nat Methods. 2007 Nov;4(11):923-5
pubmed: 17952086
Nat Biotechnol. 2016 Jul 12;34(7):706-8
pubmed: 27404878
Glycobiology. 2003 Jun;13(6):427-34
pubmed: 12626420
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3083-8
pubmed: 14976248
Plant Biotechnol J. 2013 Dec;11(9):1034-43
pubmed: 23898885
Plant Mol Biol. 2017 Dec;95(6):593-606
pubmed: 29119347
Biotechnol Bioeng. 2009 Mar 1;102(4):1074-86
pubmed: 18988263
J Biotechnol. 2012 Jan;157(1):130-9
pubmed: 22024589
Biotechnol Adv. 2000 Mar;18(1):1-22
pubmed: 14538116
Biotechnol J. 2012 Apr;7(4):537-45
pubmed: 22125283
J Control Release. 2011 Feb 10;149(3):323-31
pubmed: 21047542
Biotechnol J. 2012 Dec;7(12):1462-72
pubmed: 22829536
J Biol Chem. 2011 Feb 25;286(8):6152-64
pubmed: 21169367
J Mol Biol. 2015 Mar 27;427(6 Pt A):1159-75
pubmed: 24968227
Glycobiology. 2005 Oct;15(10):965-81
pubmed: 15901675
PLoS One. 2014 Dec 10;9(12):e114628
pubmed: 25493940
Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2899-904
pubmed: 11226338
Biotechnol Bioeng. 2011 Aug;108(8):1954-64
pubmed: 21351076
Biochim Biophys Acta. 2011 Mar;1808(3):912-24
pubmed: 20599535
Mol Ther. 2008 Aug;16(8):1459-66
pubmed: 18523448
Methods Mol Biol. 1995;49:1-32
pubmed: 8563796
Mol Ther. 2018 May 2;26(5):1366-1374
pubmed: 29606503
Biochem Biophys Res Commun. 2016 Oct 14;479(2):266-271
pubmed: 27638310
BMC Biotechnol. 2008 Dec 23;8:95
pubmed: 19105816

Auteurs

Florian Cardon (F)

Root Lines Technology SA, Amiens, France.

Roser Pallisse (R)

Root Lines Technology SA, Amiens, France.

Muriel Bardor (M)

Laboratoire Glyco-MEV EA4358, UNIROUEN, Normandie Université, Rouen, France.
Institut Universitaire de France (I.U.F.), Paris Cedex 05, France.

Aurore Caron (A)

Root Lines Technology SA, Amiens, France.

Jessica Vanier (J)

Laboratoire Glyco-MEV EA4358, UNIROUEN, Normandie Université, Rouen, France.

Jean Pierre Ele Ekouna (JP)

Biologie des Plantes et Innovation (BIOPI), Université de Picardie Jules Verne, Amiens, France.

Patrice Lerouge (P)

Laboratoire Glyco-MEV EA4358, UNIROUEN, Normandie Université, Rouen, France.

Michèle Boitel-Conti (M)

Biologie des Plantes et Innovation (BIOPI), Université de Picardie Jules Verne, Amiens, France.

Marina Guillet (M)

Root Lines Technology SA, Amiens, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH